SummaryThe metabolic impact of the common peroxisome proliferator-activated receptor gamma isoform 2 (PPARγ2) variant Pro12Ala in human populations has been widely debated. We demonstrate, using a Pro12Ala knockin model, that on chow diet, Ala/Ala mice are leaner, have improved insulin sensitivity and plasma lipid profiles, and have longer lifespans. Gene-environment interactions played a key role as high-fat feeding eliminated the beneficial effects of the Pro12Ala variant on adiposity, plasma lipids, and insulin sensitivity. The underlying molecular mechanisms involve changes in cofactor interaction and adiponectin signaling. Altogether, our results establish the Pro12Ala variant of Pparγ2 as an important modulator in metabolic control th...
Protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala polymorph...
<p>The protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala po...
SummarySNPs affecting disease risk often reside in non-coding genomic regions. Here, we show that SN...
SummaryThe metabolic impact of the common peroxisome proliferator-activated receptor gamma isoform 2...
International audienceThe metabolic impact of the common peroxisome proliferator-activated receptor ...
International audienceThe metabolic impact of the common peroxisome proliferator-activated receptor ...
The metabolic impact of the common peroxisome proliferator-activated receptor gamma isoform 2 (PPARg...
Obesity and type 2 diabetes mellitus (T2D) are two major public health problems that have motivated ...
The global epidemic of obesity and type II diabetes has led to a growing interest in the underlying ...
Peroxisome proliferator receptor gamma (PPARγ) is a nuclear receptor first identified for its role i...
Metabolic syndrome, a clustering of conditions including obesity, insulin resistance, and hypertensi...
International audienceObjective: The Pro12Ala polymorphism of the Peroxisome Proliferator Activated ...
Several genetic variants of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2), a molec...
The peroxisome proliferator-activated receptor-γ gene (PPARG) has been implicated in the etiology of...
AbstractObesity-associated diabetes is epidemic in industrialized societies. The nuclear receptor pe...
Protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala polymorph...
<p>The protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala po...
SummarySNPs affecting disease risk often reside in non-coding genomic regions. Here, we show that SN...
SummaryThe metabolic impact of the common peroxisome proliferator-activated receptor gamma isoform 2...
International audienceThe metabolic impact of the common peroxisome proliferator-activated receptor ...
International audienceThe metabolic impact of the common peroxisome proliferator-activated receptor ...
The metabolic impact of the common peroxisome proliferator-activated receptor gamma isoform 2 (PPARg...
Obesity and type 2 diabetes mellitus (T2D) are two major public health problems that have motivated ...
The global epidemic of obesity and type II diabetes has led to a growing interest in the underlying ...
Peroxisome proliferator receptor gamma (PPARγ) is a nuclear receptor first identified for its role i...
Metabolic syndrome, a clustering of conditions including obesity, insulin resistance, and hypertensi...
International audienceObjective: The Pro12Ala polymorphism of the Peroxisome Proliferator Activated ...
Several genetic variants of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2), a molec...
The peroxisome proliferator-activated receptor-γ gene (PPARG) has been implicated in the etiology of...
AbstractObesity-associated diabetes is epidemic in industrialized societies. The nuclear receptor pe...
Protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala polymorph...
<p>The protective mechanisms of peroxisome proliferator-activated receptor gamma (PPARγ) Pro12Ala po...
SummarySNPs affecting disease risk often reside in non-coding genomic regions. Here, we show that SN...